Annual result: details
in CHF
2023
2022
ASSETS
Liquid assets
1'790'998
2'472'752
Securities
24'193'709
22'716'961
Accounts receivable
2'133'897
2'098'102
Other current receivables
133'908
173'992
Accruals
646'485
419'889
Current assets
28'898'997
27'881'696
Financial assets
155'032
155'000
Tangible assets
811'232
947'676
Intangible fixed assets
1'177'970
487'835
Fixed assets
2'144'234
1'590'511
ASSETS
31'043'231
29'472'207
LIABILITIES
Accounts payable
1'236'214
1'821'687
Other current liabilities
1'171'750
764'131
Deferrals
1'532'992
981'216
Short-term liabilities
3'940'956
3'567'034
Long-term provisions
1'034'789
1'034'789
Fund capital
11'991'440
11'363'342
Long-term liabilities
13'026'229
12'398'131
Capital stock
2'000'000
2'000'000
Statutory retained earnings
840'130
840'130
Committed capital
10'908'267
10'367'699
Unrestricted capital
299'213
477'884
Annual result
28'436
-178'671
Equity capital-Organisational capital
14'076'046
13'507'042
LIABILITIES
31'043'231
29'472'207
Statement of accounts at 31 December 2023
in CHF
2023
2022
Income from donations, other contributions
1'790'189
2'938'177
Income from public remit
1'677'641
595'071
Income from donor searches and transplants
15'120'212
14'526'059
Income from services
1'078'817
1'351'246
Income from project contributions of charitable organisations,
non-profit organisations
1'553'609
1'461'331
Operating income
21'220'468
20'871'884
Expenditure on national assigned duties
-7'086
-4'103
Cost of donor recruitment and care
-385'569
-441'547
Cost of donor searches and transplants
-8'146'052
-7'660'212
Expenditure materials and services
-1'438'998
-1'548'972
Staff costs
-6'687'912
-6'588'680
Other operating result
-2'046'430
-1'807'716
Expenditure – administration, consulting, and IT
-1'747'290
-1'475'728
Depreciation
-331'441
-223'506
Total operating expenditure
-20'790'778
-19'750'464
Operating result
429'690
1'121'420
Financial expense
-542'126
-3'853'814
Financial income
1'309'538
475'458
Net financial income
767'412
-3'378'356
Income from disposals of fixed assets
-
7'141
Annual result before change in fund capital
1'197'102
-2'249'795
Transfer to fund capital
-4'357'033
-4'142'049
Use of fund capital
3'728'935
3'701'442
Annual result before change in capital of the organisation
569'004
-2'690'402
Appropriation of earnings
Change in organisational capital
-540'568
-2'511'731
Annual result
28'436
-178'671
Solidarity fund
In 2023, the fund paid out a total of CHF 494,400. These payments helped to ease the difficult financial situations of 26 HIV patients, or their families, and of 2 people infected with hepatitis.
Solidarity fund Blood
The solidarity fund Blood was set up by the Swiss Red Cross in 1993. The payments from this fund are intended to ease the suffering of people who have been infected with dangerous diseases through blood products. The large majority of these patients were infected with HIV or hepatitis C in the 1980s or early 1990s. Through this fund, which was set up specifically for this purpose, the Swiss Red Cross pays tribute to the solidarity felt for people harmed by blood products received via transfusions. Payment of benefits from the fund is a voluntary undertaking, as neither Swiss Transfusion SRC nor the Swiss Red Cross can be held responsible for the residual risk associated with blood products.
In 2023, the Red Cross Council and the SRC Humanitarian Foundation approved the indefinite continuance of the payments into the solidarity fund for the benefit of the 28 people.
in CHF
2023
2022
Accounts
494'400
494'400
Staff costs
18'400
20'000
Material expenditure
32'561
32'673
Total expenditure
545'361
547'073
SRC Humanitarian Foundation
650'000
650'000
Additional revenue
9'000
9'000
Total income
659'000
659'000
Surplus
113'639
111'927
Financial position at 31.12.
Assets 1.1.
2'600'998
2'489'071
Surplus 2023
113'639
111'927
Assets 31.12.
2'714'637
2'600'998